TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency

Area of Science:

• Neuroscience
• Genetics
• Mitochondrial Biology

Background:

• Loss-of-function mutations in PTEN-induced kinase 1 (PINK1) are a known cause of early-onset Parkinson disease (PD).
• Zebrafish (Danio rerio) offer a valuable vertebrate model for studying neurodegenerative diseases like PD.

Purpose of the Study:

• To investigate the molecular mechanisms underlying mitochondrial dysfunction and dopaminergic neuron loss in a pink1 mutant zebrafish line.
• To identify novel therapeutic targets for PINK1-related PD.

Main Methods:

• Assessment of dopaminergic neuron count, mitochondrial function, and morphology in pink1 mutant zebrafish embryos and adults.
• Genome-wide gene expression analysis to identify pathogenic pathways.
• Functional experiments to explore neurodevelopmental effects and microglial activation.

Main Results:

• PINK1 deficiency in zebrafish led to dopaminergic neuron loss, impaired mitochondrial function, and altered morphology.
• Increased expression of TigarB (zebrafish TIGAR orthologue) was observed in pink1 mutant larvae.
• Inactivation of TigarB normalized mitochondrial function and rescued dopaminergic neurons, while microglial activation did not appear to be a primary pathogenic factor.

Conclusions:

• Pink1(-/-) zebrafish represent the first vertebrate model exhibiting dopaminergic neuron loss due to PINK1 deficiency.
• TIGAR emerges as a potential therapeutic target for modifying disease progression in PINK1-related Parkinson disease.